Dapagliflozin Plus Pioglitazone in T1DM

NCT03878459 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Pioglitazone 45 mg
DRUG: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio